# ROLVEDON
> **BLA761148** · Biologics License Application · Sponsor: SPECTRUM PHARMS · Approved 2022-09-09
## Drug
- **FDA Application Number:** BLA761148
- **Application type:** Biologics License Application
- **Brand name:** ROLVEDON
- **Generic name:** EFLAPEGRASTIM-XNST
- **Active ingredients:** EFLAPEGRASTIM-XNST
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** SPECTRUM PHARMS
- **Manufacturer:** Spectrum Pharmaceuticals, Inc.
- **First approval:** 2022-09-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761148)
---
*AI Analytics · CC0 1.0*